Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2026 Filed Feb 11, 2026 22:15 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
SaleCommon Stock | 4,041 | $30.00 | $121,230.00 |
DisclosureSEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · nonDerivative · entry 2 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,382 F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 11, 2026 22:15 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
Exercise / conversionCommon Stock | 4,041 | $19.04 | $76,940.64 |
DisclosureSEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · nonDerivative · entry 1 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 02:03 UTC |
Acurio VeronicaPresident, Orthodontics
|
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative | 998 | $23.47 | $23,423.06 |
DisclosureSEC source: 0002045846-26-000002 · wk-form4_1770170631.xml · derivative · entry 1 Acurio Veronica · CIK 0002045846 · President, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 998 Underlying: Common Stock · 998 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 02:04 UTC |
Befidi RobertPresident, Diagnostics
|
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative | 998 | $23.47 | $23,423.06 |
DisclosureSEC source: 0002012361-26-000002 · wk-form4_1770170663.xml · derivative · entry 1 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,149 Underlying: Common Stock · 998 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:03 UTC |
Kaabi Faez CChief Accounting Officer
|
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative | 1,186 | $23.47 | $27,835.42 |
DisclosureSEC source: 0001993528-26-000001 · wk-form4_1770170636.xml · derivative · entry 1 Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,040 Underlying: Common Stock · 1,186 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntarily defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntarily defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 02:04 UTC |
Hammes Eric D.Chief Financial Officer
|
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative | 1,119 | $23.47 | $26,262.93 |
DisclosureSEC source: 0001610493-26-000002 · wk-form4_1770170652.xml · derivative · entry 1 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,119 Underlying: Common Stock · 1,119 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 02:04 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative | 4,091 | $23.47 | $96,015.77 |
DisclosureSEC source: 0001626337-26-000002 · wk-form4_1770170646.xml · derivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,091 Underlying: Common Stock · 4,091 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:04 UTC |
Nance Mark EGeneral Counsel
|
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative | 2,006 | $23.47 | $47,080.82 |
DisclosureSEC source: 0001755882-26-000002 · wk-form4_1770170641.xml · derivative · entry 1 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,587 Underlying: Common Stock · 2,006 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made. F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 02:04 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
GrantExecutive Deferred Incentive Program - Envista Stock Fund · Derivative | 2,919 | $21.71 | $63,371.49 |
DisclosureSEC source: 0001788632-26-000002 · wk-form4_1770170658.xml · derivative · entry 1 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,357 Underlying: Common Stock · 2,919 shares Expires not disclosed F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis. F2 · derivative.exercise_date: All contributions to the reporting person's EDIP Stock Fund are 90% vested and will vest at 10% each subsequent year on 1/1 until he reaches 10 years of EDIP participation or retirement eligibility. Upon termination of employment, the EDIP Stock Fund balance is settled in shares of Envista common stock. F2 · derivative.expiration_date: All contributions to the reporting person's EDIP Stock Fund are 90% vested and will vest at 10% each subsequent year on 1/1 until he reaches 10 years of EDIP participation or retirement eligibility. Upon termination of employment, the EDIP Stock Fund balance is settled in shares of Envista common stock. F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "EDIP Stock Fund") in the reporting person's Executive Deferred Incentive Program (the "EDIP") account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last trading day of the prior year. Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 21:25 UTC |
Keel Paul ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 54,097 | $20.35 | $1,100,873.95 |
DisclosureSEC source: 0001626337-25-000003 · wk-form4_1762291503.xml · nonDerivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,555 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:15 UTC |
Nilsson StefanPresident, Nobel Biocare
|
Tax withholdingCommon Stock | 804 | $21.12 | $16,980.48 |
DisclosureSEC source: 0002045818-25-000003 · wk-form4_1756325732.xml · nonDerivative · entry 1 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,941 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:13 UTC |
Acurio VeronicaPresident, Orthodontics
|
Tax withholdingCommon Stock | 5,422 | $21.12 | $114,512.64 |
DisclosureSEC source: 0002045846-25-000003 · wk-form4_1756325598.xml · nonDerivative · entry 1 Acurio Veronica · CIK 0002045846 · President, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,323 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:19 UTC |
Befidi RobertPresident, Diagnostics
|
Tax withholdingCommon Stock | 3,454 | $21.12 | $72,948.48 |
DisclosureSEC source: 0002012361-25-000003 · wk-form4_1756325973.xml · nonDerivative · entry 1 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,504 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:17 UTC |
Hammes Eric D.Chief Financial Officer
|
Tax withholdingCommon Stock | 7,654 | $21.12 | $161,652.48 |
DisclosureSEC source: 0001610493-25-000003 · wk-form4_1756325855.xml · nonDerivative · entry 1 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,788 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:09 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
SaleCommon Stock | 15,000 | $21.60 | $324,000.00 |
DisclosureSEC source: 0001788632-25-000003 · wk-form4_1756325384.xml · nonDerivative · entry 1 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,382 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 20:17 UTC |
Pierce James AndrewDirector
|
GrantCommon Stock | 9,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-035071 · wk-form4_1752697042.xml · nonDerivative · entry 1 Pierce James Andrew · CIK 0001886518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,155 F1 · shares: Consists of Restricted Stock Units ("RSUs") that were granted upon the Reporting Person's appointment as a director of the Issuer on July 14, 2025. The RSUs will vest on June 10, 2026. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:55 UTC |
Jain VivekDirector
|
GrantCommon Stock | 10,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031066 · wk-form4_1749761728.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,615 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:55 UTC |
TSINGOS CHRISTINE ADirector
|
GrantCommon Stock | 10,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031063 · wk-form4_1749761708.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,600 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:55 UTC |
Raskas DanielDirector
|
GrantCommon Stock | 10,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031067 · wk-form4_1749761738.xml · nonDerivative · entry 1 Raskas Daniel · CIK 0001306860 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,680 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:55 UTC |
GALLAHUE KIERANDirector
|
GrantCommon Stock | 10,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031069 · wk-form4_1749761747.xml · nonDerivative · entry 1 GALLAHUE KIERAN · CIK 0001308428 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,680 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:54 UTC |
Huennekens R ScottDirector
|
GrantCommon Stock | 14,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031060 · wk-form4_1749761687.xml · nonDerivative · entry 1 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,520 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:55 UTC |
Carruthers WendyDirector
|
GrantCommon Stock | 10,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031064 · wk-form4_1749761718.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,610 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:55 UTC |
Hulit Barbara B.Director
|
GrantCommon Stock | 10,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031062 · wk-form4_1749761698.xml · nonDerivative · entry 1 Hulit Barbara B. · CIK 0001682154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,820 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 25, 2025 Filed May 27, 2025 20:45 UTC |
Keel Paul ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 12,787 | $16.72 | $213,798.64 |
DisclosureSEC source: 0001628280-25-027962 · wk-form4_1748378753.xml · nonDerivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401,652 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 22:27 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
GrantCommon Stock | 8,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000014 · wk-form4_1740695247.xml · nonDerivative · entry 2 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,382 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Nilsson StefanPresident, Nobel Biocare
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 24,010 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001757073-25-000011 · wk-form4_1740695216.xml · derivative · entry 3 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,010 Underlying: Common Stock · 24,010 shares Expires 2035-02-25 F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Nilsson StefanPresident, Nobel Biocare
|
GrantPerformance Share Unit · Derivative | 18,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000011 · wk-form4_1740695216.xml · derivative · entry 2 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,960 Underlying: Common Stock · 18,960 shares Expires not disclosed F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Nilsson StefanPresident, Nobel Biocare
|
GrantCommon Stock | 10,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000011 · wk-form4_1740695216.xml · nonDerivative · entry 1 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,745 F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Acurio VeronicaPresident, Orthodontics
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 24,010 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001757073-25-000012 · wk-form4_1740695226.xml · derivative · entry 3 Acurio Veronica · CIK 0002045846 · President, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,010 Underlying: Common Stock · 24,010 shares Expires 2035-02-25 F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Acurio VeronicaPresident, Orthodontics
|
GrantPerformance Share Unit · Derivative | 18,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000012 · wk-form4_1740695226.xml · derivative · entry 2 Acurio Veronica · CIK 0002045846 · President, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,960 Underlying: Common Stock · 18,960 shares Expires not disclosed F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Acurio VeronicaPresident, Orthodontics
|
GrantCommon Stock | 10,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000012 · wk-form4_1740695226.xml · nonDerivative · entry 1 Acurio Veronica · CIK 0002045846 · President, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,745 F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:26 UTC |
Befidi RobertPresident, Diagnostics
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 24,010 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001757073-25-000010 · wk-form4_1740695207.xml · derivative · entry 4 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,010 Underlying: Common Stock · 24,010 shares Expires 2035-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:26 UTC |
Befidi RobertPresident, Diagnostics
|
GrantPerformance Share Unit · Derivative | 18,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000010 · wk-form4_1740695207.xml · derivative · entry 3 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,960 Underlying: Common Stock · 18,960 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:26 UTC |
Befidi RobertPresident, Diagnostics
|
GrantCommon Stock | 10,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000010 · wk-form4_1740695207.xml · nonDerivative · entry 2 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,958 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:26 UTC |
Befidi RobertPresident, Diagnostics
|
Tax withholdingCommon Stock | 1,123 | $20.66 | $23,201.18 |
DisclosureSEC source: 0001757073-25-000010 · wk-form4_1740695207.xml · nonDerivative · entry 1 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,668 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 17:27 UTC |
Kaabi Faez CChief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 22,600 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001757073-25-000015 · wk-form4_1740695258.xml · derivative · entry 3 Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,600 Underlying: Common Stock · 22,600 shares Expires 2035-02-25 F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 17:27 UTC |
Kaabi Faez CChief Accounting Officer
|
GrantCommon Stock | 9,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000015 · wk-form4_1740695258.xml · nonDerivative · entry 2 Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,996 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 17:27 UTC |
Kaabi Faez CChief Accounting Officer
|
Tax withholdingCommon Stock | 4,319 | $20.66 | $89,230.54 |
DisclosureSEC source: 0001757073-25-000015 · wk-form4_1740695258.xml · nonDerivative · entry 1 Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,311 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSUs"). Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:26 UTC |
Hammes Eric D.Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 36,720 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001757073-25-000009 · wk-form4_1740695196.xml · derivative · entry 3 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,720 Underlying: Common Stock · 36,720 shares Expires 2035-02-25 F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:26 UTC |
Hammes Eric D.Chief Financial Officer
|
GrantPerformance Share Unit · Derivative | 28,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000009 · wk-form4_1740695196.xml · derivative · entry 2 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,995 Underlying: Common Stock · 28,995 shares Expires not disclosed F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:26 UTC |
Hammes Eric D.Chief Financial Officer
|
GrantCommon Stock | 15,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000009 · wk-form4_1740695196.xml · nonDerivative · entry 1 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,442 F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 153,660 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001757073-25-000013 · wk-form4_1740695237.xml · derivative · entry 3 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,660 Underlying: Common Stock · 153,660 shares Expires 2035-02-25 F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantPerformance Share Unit · Derivative | 181,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000013 · wk-form4_1740695237.xml · derivative · entry 2 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,985 Underlying: Common Stock · 181,985 shares Expires not disclosed F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantCommon Stock | 65,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000013 · wk-form4_1740695237.xml · nonDerivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414,439 F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 17:26 UTC |
Nance Mark EGeneral Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 42,370 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001757073-25-000008 · wk-form4_1740695186.xml · derivative · entry 4 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,370 Underlying: Common Stock · 42,370 shares Expires 2035-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 17:26 UTC |
Nance Mark EGeneral Counsel
|
GrantPerformance Share Unit · Derivative | 33,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000008 · wk-form4_1740695186.xml · derivative · entry 3 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,455 Underlying: Common Stock · 33,455 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 17:26 UTC |
Nance Mark EGeneral Counsel
|
GrantCommon Stock | 18,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000008 · wk-form4_1740695186.xml · nonDerivative · entry 2 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,945 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 17:26 UTC |
Nance Mark EGeneral Counsel
|
Tax withholdingCommon Stock | 3,691 | $20.66 | $76,256.06 |
DisclosureSEC source: 0001757073-25-000008 · wk-form4_1740695186.xml · nonDerivative · entry 1 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,790 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 19,780 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001757073-25-000014 · wk-form4_1740695247.xml · derivative · entry 4 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,780 Underlying: Common Stock · 19,780 shares Expires 2035-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:27 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
GrantPerformance Share Unit · Derivative | 15,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-25-000014 · wk-form4_1740695247.xml · derivative · entry 3 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,615 Underlying: Common Stock · 15,615 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.